These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 29363233)
1. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods. Liu HN; Liu TT; Wu H; Chen YJ; Tseng YJ; Yao C; Weng SQ; Dong L; Shen XZ Cancer Sci; 2018 Apr; 109(4):1185-1194. PubMed ID: 29363233 [TBL] [Abstract][Full Text] [Related]
2. Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer. Liu HN; Wu H; Tseng YJ; Chen YJ; Zhang DY; Zhu L; Dong L; Shen XZ; Liu TT BMC Cancer; 2018 Apr; 18(1):415. PubMed ID: 29653559 [TBL] [Abstract][Full Text] [Related]
3. Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma. Liu HN; Wu H; Chen YJ; Tseng YJ; Bilegsaikhan E; Dong L; Shen XZ; Liu TT Oncotarget; 2017 Dec; 8(65):108810-108824. PubMed ID: 29312570 [TBL] [Abstract][Full Text] [Related]
4. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573 [TBL] [Abstract][Full Text] [Related]
5. Specificity of metabolic colorectal cancer biomarkers in serum through effect size. Di Giovanni N; Meuwis MA; Louis E; Focant JF Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702 [TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223 [TBL] [Abstract][Full Text] [Related]
8. Identification of a circulating microRNA signature for colorectal cancer detection. Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885 [TBL] [Abstract][Full Text] [Related]
9. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer. Bilegsaikhan E; Liu HN; Shen XZ; Liu TT J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis. Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318 [TBL] [Abstract][Full Text] [Related]
12. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer]. Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770 [No Abstract] [Full Text] [Related]
13. A novel serum metabolomics-based diagnostic approach for colorectal cancer. Nishiumi S; Kobayashi T; Ikeda A; Yoshie T; Kibi M; Izumi Y; Okuno T; Hayashi N; Kawano S; Takenawa T; Azuma T; Yoshida M PLoS One; 2012; 7(7):e40459. PubMed ID: 22792336 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
15. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
16. A plasma microRNA panel for early detection of colorectal cancer. Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911 [TBL] [Abstract][Full Text] [Related]
17. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the diagnostic value of various microRNAs in blood for colorectal cancer: a systematic review and network meta-analysis. Xu J; Pan L; Wu D; Yao L; Jiang W; Min J; Xu S; Deng Z BMC Cancer; 2024 Jun; 24(1):770. PubMed ID: 38926893 [TBL] [Abstract][Full Text] [Related]
19. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer. Shi Y; Liu Z J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-193a-3p as a Valuable Biomarker for Discriminating between Colorectal Cancer and Colorectal Adenoma Patients. Fabijanec M; Hulina-Tomašković A; Štefanović M; Verbanac D; Ćelap I; Somborac-Bačura A; Grdić Rajković M; Demirović A; Ramić S; Krušlin B; Rumora L; Čeri A; Koržinek M; Petrik J; Ljubičić N; Baršić N; Barišić K Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]